Lv3
270 积分 2022-12-29 加入
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
24天前
已完结
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Data from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
2个月前
已关闭
Gentiopicroside ameliorates glucose and lipid metabolism in T2DM via targeting FGFR1
2个月前
已完结
Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer
2个月前
已完结
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
2个月前
已完结
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2个月前
已完结
Carnitine palmitoyltransferase 1C: From cognition to cancer
2个月前
已完结
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
2个月前
已完结
皖公网安备34019202002308
